DocCheck AG
DocCheck AG Fundamental Analysis
DocCheck AG (AJ91.DE) shows moderate financial fundamentals with a PE ratio of 11.98, profit margin of 9.53%, and ROE of 13.28%. The company generates $0.1B in annual revenue with weak year-over-year growth of 0.69%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 50.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze AJ91.DE's fundamental strength across five key dimensions:
Efficiency Score
WeakAJ91.DE struggles to generate sufficient returns from assets.
Valuation Score
ExcellentAJ91.DE trades at attractive valuation levels.
Growth Score
WeakAJ91.DE faces weak or negative growth trends.
Financial Health Score
ExcellentAJ91.DE maintains a strong and stable balance sheet.
Profitability Score
WeakAJ91.DE struggles to sustain strong margins.
Key Financial Metrics
Is AJ91.DE Expensive or Cheap?
P/E Ratio
AJ91.DE trades at 11.98 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, AJ91.DE's PEG of 0.12 indicates potential undervaluation.
Price to Book
The market values DocCheck AG at 1.54 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 6.53 times EBITDA. This is generally considered low.
How Well Does AJ91.DE Make Money?
Net Profit Margin
For every $100 in sales, DocCheck AG keeps $9.53 as profit after all expenses.
Operating Margin
Core operations generate 14.72 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $13.28 in profit for every $100 of shareholder equity.
ROA
DocCheck AG generates $9.58 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
DocCheck AG produces operating cash flow of $5.95M, showing steady but balanced cash generation.
Free Cash Flow
DocCheck AG produces free cash flow of $2.42M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.48 in free cash annually.
FCF Yield
AJ91.DE converts 3.79% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
11.98
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.12
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.54
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.14
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.10
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.18
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.13
vs 25 benchmark
ROA
Return on assets percentage
0.10
vs 25 benchmark
ROCE
Return on capital employed
0.18
vs 25 benchmark
How AJ91.DE Stacks Against Its Sector Peers
| Metric | AJ91.DE Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 11.98 | 28.81 | Better (Cheaper) |
| ROE | 13.28% | 643.00% | Weak |
| Net Margin | 9.53% | -44312.00% (disorted) | Weak |
| Debt/Equity | 0.10 | 0.36 | Strong (Low Leverage) |
| Current Ratio | 3.18 | 4.50 | Strong Liquidity |
| ROA | 9.58% | -17799.00% (disorted) | Weak |
AJ91.DE outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews DocCheck AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
63.64%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
65.49%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
322.40%
Industry Style: Defensive, Growth, Innovation
High Growth